Results 11 to 20 of about 12,469 (206)
Progressive multifocal leukoencephalopathy: new concepts [PDF]
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the CNS caused by reactivation of JC virus (JCV) in a setting of cellular immunosuppression.
Marco A. Lima
doaj +2 more sources
Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report [PDF]
Introduction Progressive multifocal leukoencephalopathy is an opportunistic infection occurring in patients with severe cellular immunodeficiency. This case highlights the role of cellular immunodeficiency in the reactivation of John Cunningham virus in ...
Troppmann Martina +3 more
doaj +2 more sources
Progressive multifocal leukoencephalopathy: rheumatological aspects
Progressive multifocal leukoencephalopathy (PML) is a severe progressive viral disease that affects the central nervous system in patients with immunodeficiency.
Boris Sergeevich Belov
doaj +3 more sources
Progressive multifocal leukoencephalopathy
doi:10.3969/j.issn.1672⁃6731.2020.03 ...
Xiao⁃ling YAN
doaj +2 more sources
Immunology of progressive multifocal leukoencephalopathy [PDF]
The high prevalence of asymptomatic JC polyomavirus (JCV) infection in the general population indicates coexistence with the human host and efficient immune control in healthy individuals. For unknown reasons, kidney-resident archetypic JCV strains can turn into neurotropic JCV strains which in hereditary or acquired states of immunodeficiency cause ...
Jelcic, Ivan +4 more
openaire +6 more sources
Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy [PDF]
Progressive multifocal leukoencephalopathy (PML) is a rare disease of the immunosuppression that results from neurotropic invasion of the JC virus which leads to demyelination of oligodendrocytes.
Chandra Punch +2 more
doaj +2 more sources
Multifocal Leukoencephalopathy
A 15-year-old boy with Wiskott-Aldrich syndrome complicated by progressive multifocal leukoencephalopathy (PML) is reported from the University of Miami School of Medicine, FL, and the National Institute of Neurological Disorders and Stroke, Bethesda, MD.
J Gordon Millichap
doaj +2 more sources
Katie Yoganathan1, David Brown2, Kathir Yoganathan31Cardiff Medical School, Cardiff, Wales, UK; 2Virus Reference Department, Microbiology Services, Health Protection Agency, London, UK; 3Singleton Hospital, Abertawe Bro Morgannwg University Health Board,
Yoganathan K, Brown D, Yoganathan K
doaj +1 more source
The Effect of Ocrelizumab on Anti-JC Virus Antibody Index. [PDF]
Synopsis: This study of 553 MS patients found that anti‐JC virus (JCV) antibody indices remain stable during the first 2 years of ocrelizumab treatment. While peripheral B‐cells were significantly depleted and serum immunoglobulins (IgG, IgM, IgA) showed modest declines, the JCV antibody index did not change significantly.
Virupakshaiah A +8 more
europepmc +2 more sources
Progressive multifocal leukoencephalopathy [PDF]
A 58-year-old woman admitted to the hospital had a 3-month history of progressive neurologic deterioration characterized by severe global aphasia and bilateral limb weakness, greater on the right. The patient had a 10-year history of systemic lupus erythematosus (SLE). Polyarthritis had been present for 6 weeks before the …
Henderson, R. D. +3 more
openaire +4 more sources

